Viemed Healthcare US ( (VMD) ) has released its Q3 earnings. Here is a breakdown of the information Viemed Healthcare US presented to its investors.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Viemed Healthcare, Inc. is a U.S.-based in-home clinical care provider specializing in post-acute respiratory healthcare equipment and services, including non-invasive ventilators and sleep therapy. The company focuses on delivering effective in-home treatment through a combination of clinical expertise and advanced technology.
Viemed Healthcare has reported a record-breaking third quarter for 2025, with net revenues reaching $71.9 million, marking a 24% increase from the same period last year. The company attributes this growth to strategic acquisitions and an expanding patient base across its major service lines.
Key financial highlights include a net income of $3.5 million and an adjusted EBITDA of $16.1 million, reflecting a 15.5% increase year-over-year. The acquisition of Lehan’s Medical Equipment has been immediately accretive to earnings, and the company has successfully repurchased over 1.7 million shares, enhancing shareholder value. Viemed also reported strong cash flow, with $18.4 million generated from operating activities in the quarter.
Looking ahead, Viemed has updated its full-year 2025 guidance, projecting net revenues between $271 million and $273 million, and adjusted EBITDA between $60 million and $62 million. The company remains focused on strategic growth opportunities and maintaining financial strength to support long-term success.